Relationship between skin involvement and disease burden in patients with mild to moderate plaque psoriasis: Real-world findings From CorEvitas' Psoriasis Registry

被引:0
|
作者
Ogdie, Alexis [1 ]
Strober, Bruce [2 ]
Lebwohl, Mark [3 ]
机构
[1] Univ Pennsylvania, Philadelphia, PA USA
[2] Yale Univ, New Haven, CT USA
[3] Icahn Sch Med Mt Sinai, New York, NY USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
33933
引用
收藏
页码:AB103 / AB103
页数:1
相关论文
共 50 条
  • [21] The Effectiveness of Guselkumab by BMI Category Among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry
    Armstrong, April W.
    Fitzgerald, Timothy
    McLean, Robert R.
    Teeple, Amanda
    Uy, Jonathan P.
    Olurinde, Mobolaji
    Rowland, Katelyn
    Guo, Lin
    Shan, Ying
    Callis Duffin, Kristina
    [J]. ADVANCES IN THERAPY, 2023, 40 (05) : 2493 - 2508
  • [22] Impact of psoriasis disease severity and special area involvement on patient-reported outcomes in the real world: an analysis from the CorEvitas psoriasis registry
    Strober, Bruce
    Duffin, Kristina Callis
    Lebwohl, Mark
    Sima, Adam
    Janak, Jud
    Patel, Manish
    Photowala, Huzefa
    Garg, Vishvas
    Bagel, Jerry
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01) : 2287401
  • [23] Real-world health outcomes in US adult patients with mild to moderate plaque psoriasis taking topical therapy
    Kaplan, David
    Hetherington, James
    Lucas, James
    Khilfeh, Ibrahim
    Nazareth, Tara
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (06) : 2844 - 2852
  • [24] Greater disease burden associated with palmoplantar pustulosis versus plaque psoriasis: Real-world evidence from the North American-based Corrona Psoriasis Registry
    Lebwohl, Mark
    Kotowsky, Nirali
    Medeiros, Rose A.
    Foster, Nicole
    Janak, Judson
    Valdecantos, Wendell C.
    Flack, Mary
    Golembesky, Amanda K.
    Strober, Bruce
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB4 - AB4
  • [25] Real-world burden of comorbidities in US patients with psoriasis
    Shah, Kamal
    Mellars, Lillian
    Changolkar, Arun
    Feldman, Steven R.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (02) : 287 - +
  • [26] Real-world burden of comorbidities in US patients with psoriasis
    Shah, Kamal
    Paris, Maria
    Mellars, Lillian
    Changolkar, Arun
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB215 - AB215
  • [27] Ixekizumab for the treatment of the patients with moderate to severe plaque psoriasis: Clinical data from a real-world experience
    Gonulal, Melis
    Altunay, Ilknur Kivanc
    Dogan, Sinan
    Turkmen, Meltem
    Balci, Didem Didar
    Ozturkcan, Serap
    [J]. DERMATOLOGIC THERAPY, 2022, 35 (12)
  • [28] Real-world safety of secukinumab in patients with moderate to severe chronic plaque psoriasis in Latin America and Canada: Results from the PURE registry
    Beecker, Jennifer
    Papp, Kim Alexander
    Gooderham, Melinda
    Ho, Vincent
    Lynde, Charles W.
    Robern, Michael
    Rampakakis, Emmanouil
    Boucher, Annie
    Hussein, Shamiza
    Rihakova, Lenka
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB241 - AB241
  • [29] Characterization of real-world psoriasis patients with and without a history of depression: The Corrona Psoriasis Registry
    Shahriari, Neda
    Lin, Tin-Chi
    Litman, Heather J.
    Dube, Blessing
    McLean, Robert R.
    Shah-Riari, Mona
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (05) : 1444 - 1447
  • [30] Effectiveness and safety of secukinumab in Chinese patients with moderate to severe plaque psoriasis in real-world practice
    Zhou, Jian
    Yuan, Yuan
    Liu, Yanhua
    Chu, Mengyang
    Liu, Huan
    Liu, Qian
    Wang, Rui
    Shao, Shuai
    Wang, Gang
    Yu, Chen
    [J]. EXPERIMENTAL DERMATOLOGY, 2024, 33 (01)